Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0000945621-23-000180
Filing Date
2023-03-24
Accepted
2023-03-24 12:59:21
Documents
1
Effectiveness Date
2023-03-24
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 9483
  Complete submission text file 0000945621-23-000180.txt   10654
Mailing Address 777 THIRD AVENUE 25TH FLOOR NEW YORK NY 10017
Business Address 777 THIRD AVENUE 25TH FLOOR NEW YORK NY 10017 212.698.4595
Innovatus Life Sciences Lending Fund I, LP (Filer) CIK: 0001692825 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-282837 | Film No.: 23759021